SYS6090

SYS6090 · Shanghai JMT-Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYS6090, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: SYS6090 Combination Therapy in Advanced Lung Cancer [Phase 1, Phase 2]